| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.3M | +48.7% |
| R&D Expense | $0 | — |
| SG&A Expense | $1.0M | -3.3% |
| Operating Income | -$1.0M | +38.9% |
| Interest Expense | $932K | +6.3% |
| Net Income | -$1.8M | +24.0% |
| EPS (Basic) | -$0.03 | +25.0% |
| EPS (Diluted) | -$0.03 | +25.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $537K | +827.6% |
| Accounts Receivable | $591K | +73.4% |
| Inventory | $2K | -87.5% |
| Current Assets | $1.2M | +117.0% |
| Total Assets | $1.5M | +71.3% |
| Current Liabilities | $14.5M | +19.3% |
| Long-term Debt | $2.3M | -71.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$436K | +53.5% |
| Capital Expenditures | $23K | +52.3% |
| Investing Cash Flow | $37K | -88.6% |
| Financing Cash Flow | $879K | +35.1% |
| Free Cash Flow | -$459K | +51.8% |
| Total Liabilities |
| $16.4M |
| +16.1% |
| Stockholders' Equity | -$13.0M | -14.6% |